- Home
- PKBK vs TLSA Comparison
PKBK vs TLSA Comparison
Compare PKBK & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- TLSA
- Stock Information
- Founded
- PKBK 1999
- TLSA 2013
- Country
- PKBK United States
- TLSA United Kingdom
- Employees
- PKBK N/A
- TLSA N/A
- Industry
- PKBK Major Banks
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- PKBK Finance
- TLSA Health Care
- Exchange
- PKBK Nasdaq
- TLSA Nasdaq
- Market Cap
- PKBK 269.2M
- TLSA 240.0M
- IPO Year
- PKBK N/A
- TLSA 2000
- Fundamental
- Price
- PKBK $21.82
- TLSA $1.91
- Analyst Decision
- PKBK
- TLSA
- Analyst Count
- PKBK 0
- TLSA 0
- Target Price
- PKBK N/A
- TLSA N/A
- AVG Volume (30 Days)
- PKBK 18.4K
- TLSA 423.0K
- Earning Date
- PKBK 10-22-2025
- TLSA 05-06-2025
- Dividend Yield
- PKBK 3.33%
- TLSA N/A
- EPS Growth
- PKBK 21.49
- TLSA N/A
- EPS
- PKBK 2.83
- TLSA N/A
- Revenue
- PKBK $71,767,000.00
- TLSA N/A
- Revenue This Year
- PKBK N/A
- TLSA N/A
- Revenue Next Year
- PKBK N/A
- TLSA N/A
- P/E Ratio
- PKBK $7.39
- TLSA N/A
- Revenue Growth
- PKBK 13.64
- TLSA N/A
- 52 Week Low
- PKBK $16.94
- TLSA $0.63
- 52 Week High
- PKBK $24.29
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- PKBK 58.03
- TLSA 44.14
- Support Level
- PKBK $19.71
- TLSA $1.81
- Resistance Level
- PKBK $20.94
- TLSA $2.04
- Average True Range (ATR)
- PKBK 0.53
- TLSA 0.18
- MACD
- PKBK 0.10
- TLSA -0.03
- Stochastic Oscillator
- PKBK 100.00
- TLSA 13.46
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.